Federal grants to Nytricx, Inc.
Nytricx, Inc. in Athens, Georgia received $4.1 million in federal grants from fiscal 2021 to 2025, across 4 awards. Its largest program was Cardiovascular Diseases Research, with $2.7 million. It had no new grant money in fiscal 2025.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$4.1 million
- Awards4
- Awarded in FY 2025$0
- Largest award$2.3 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 0 | $0 |
| FY 2023 | 3 | $2.6 million |
| FY 2024 | 2 | $1.5 million |
| FY 2025 | 0 | $0 |
Programs that fund Nytricx, Inc.
| Program | Awards | Amount |
|---|---|---|
| Cardiovascular Diseases Research | 2 | $2.7 million |
| Military Medical Research and Development | 1 | $1.1 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $337,395 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $3.0 million |
| Department of Defense | 1 | $1.1 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Ultra-low fouling and anti-infective and anti-thrombotic nitric oxide releasing intravascular catheters - abstract nytricx is developing a new class of nitric oxide (NO)-releasing intravascular medical catheters to combat infection and thrombosis associated with indwelling vascular catheters. No gas | Cardiovascular Diseases Research | September 14, 2023 | $2.3 million |
| Achieving homeostasis in traumatic injuries with a nitric oxide-driven antimicrobial dressing combined with a rapid blood clotting agent | Military Medical Research and Development | August 17, 2023 | $1.1 million |
| Nitric oxide releasing ultra-slippery antibacterial surfaces for urological catheter applications - abstract urinary catheters are one of the most widely used medical devices in a hospital setting and are expected to only increase in growth due to the aging population. Out of all the various biomedi | Diabetes, Digestive, and Kidney Diseases Extramural Research | July 11, 2023 | $337,395 |
| Enhanced prosthetic vascular graft function by local release of nitric oxide - abstract endograft infection, neointimal proliferation, and thrombosis are the three main clinical complications with eptfe stent grafts affecting patients following endovascular arterial repair. These complicating factor | Cardiovascular Diseases Research | August 30, 2024 | $311,824 |
Questions people ask
How much federal grant money does Nytricx, Inc. get?
$4.1 million in 4 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Nytricx, Inc. the most?
The Department of Health and Human Services, with $3.0 million in 3 awards. The Department of Defense follow.
What is Nytricx, Inc.'s largest federal grant?
$2.3 million under Cardiovascular Diseases Research, with its first action in the period on September 14, 2023. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Nytricx, Inc.?
Its largest are Cardiovascular Diseases Research, Military Medical Research and Development and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Athens
- University of Georgia Research Foundation, Inc.
- University of Georgia
- Housing Authority of the City of Athens Georgia
- Soil & Water Conservation Commission Geo
- Clarke County School District
- Athens Tech College
- Athens-Clark Government
- Advantage Behavioral Health Systems
Largest federal grant recipients in Georgia · Federal grants in Georgia